Gilead drug fails in pancreatic cancer study
September 17, 2014 at 15:37 PM EDT
One of Gilead Sciences Inc.'s first biologic drugs failed a mid-stage trial in tough-to-treat pancreatic cancer, the company said Wednesday...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.